Sandoz publishes firm results FY24, careful FY25 prospects, biosimilars in Focus , #Sandoz #posts #steady #FY24 #results #cautious #FY25 #outlook #Biosimilars #focus
Sandoz publishes firm results FY24, careful FY25 prospects, biosimilars in Focus , #Sandoz #posts #steady #FY24 #results #cautious #FY25 #outlook #Biosimilars #focus